0001181431-12-002270.txt : 20120111 0001181431-12-002270.hdr.sgml : 20120111 20120111174158 ACCESSION NUMBER: 0001181431-12-002270 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120110 FILED AS OF DATE: 20120111 DATE AS OF CHANGE: 20120111 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Olek Elizabeth A CENTRAL INDEX KEY: 0001419066 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33095 FILM NUMBER: 12522781 MAIL ADDRESS: STREET 1: C/O ACHILLION PHARMACEUTICALS, INC. STREET 2: 300 GEORGE STREET CITY: NEW HAVEN STATE: CT ZIP: 06511 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACHILLION PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001070336 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 GEORGE STREET CITY: NEW HAVEN STATE: CT ZIP: 06511 BUSINESS PHONE: 203-624-7000 MAIL ADDRESS: STREET 1: 300 GEORGE STREET CITY: NEW HAVEN STATE: CT ZIP: 06511 4 1 rrd330439.xml OLEK 01.10.12 SALE X0304 4 2012-01-10 0 0001070336 ACHILLION PHARMACEUTICALS INC ACHN 0001419066 Olek Elizabeth A C/O ACHILLION PHARMACEUTICALS 300 GEORGE STREET NEW HAVEN CT 06511 0 1 0 0 SVP and CMO Common Stock 2012-01-10 4 M 0 12468 3.28 A 14468 D Common Stock 2012-01-10 4 S 0 12468 10.06 D 2000 D Employee Stock Option (Right to Buy) 3.28 2012-01-10 4 M 0 12468 0 D 2019-12-18 Common Stock 12468 20782 D This option was granted on December 18, 2009 and vests over a four year period with 25% of the shares vesting on the first anniversary of the date of grant and an additional 6.25% vesting at the end of each three-month period thereafter. The transactions reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by Ms. Olek on June 7, 2011. /s/ Elizabeth A. Olek 2012-01-11